Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Stephens

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinical Chemistry|September 1, 1988
Performance of two new algorithms for estimating within- and between-method carryover evaluated statisticallyT W Stephens
Biochimica Et Biophysica Acta|December 16, 1988
Inhibitors of sterol synthesis. Oleate ester of 5 alpha-cholest-8(14)-en-3 beta-ol-15-one as a substrate for pancreatic cholesterol esteraseT W Stephens, G J Schroepfer
The Biochemical Journal|April 15, 1987
Effect of starvation and diabetes on the sensitivity of carnitine palmitoyltransferase I to inhibition by 4-hydroxyphenylglyoxylateT W Stephens, R A Harris
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 27, 1998
To be lean or not to be lean. Is leptin the answer?T W Stephens, J F Caro
Biochimica Et Biophysica Acta|February 6, 1989
Inhibitors of sterol synthesis. 15-oxygenated steryl ester hydrolase activity of rat liver at neutral and acid pHT W Stephens, G J Schroepfer
The Biochemical Journal|April 1, 1984
Altered sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA in ketotic diabetic ratsG A Cook, T W Stephens, R A Harris
Diabetes|March 1, 1991
Presence of liver CGRP/amylin receptors in only nonparenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP/amylinT W Stephens, W F Heath, R N Hermeling
The Biochemical Journal|May 15, 1983
Effect of pH on malonyl-CoA inhibition of carnitine palmitoyltransferase IT W Stephens, G A Cook, R A Harris
Diabetes, Obesity & Metabolism|February 28, 2001
Lipid lowering explains the insulin sensitivity enhancing effects of a thiazolidinedione, 5-(4-(2-(2-phenyl-4-oxazolyl)ethoxy)benzyl)-2,4 thiazolidinedioneF E Yakubu-Madus, T W Stephens, W T Johnson
The Biochemical Journal|April 15, 1985
Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicineT W Stephens, A J Higgins, G A Cook, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinical Chemistry|September 1, 1988
Performance of two new algorithms for estimating within- and between-method carryover evaluated statisticallyT W Stephens
Biochimica Et Biophysica Acta|December 16, 1988
Inhibitors of sterol synthesis. Oleate ester of 5 alpha-cholest-8(14)-en-3 beta-ol-15-one as a substrate for pancreatic cholesterol esteraseT W Stephens, G J Schroepfer
The Biochemical Journal|April 15, 1987
Effect of starvation and diabetes on the sensitivity of carnitine palmitoyltransferase I to inhibition by 4-hydroxyphenylglyoxylateT W Stephens, R A Harris
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 27, 1998
To be lean or not to be lean. Is leptin the answer?T W Stephens, J F Caro
Biochimica Et Biophysica Acta|February 6, 1989
Inhibitors of sterol synthesis. 15-oxygenated steryl ester hydrolase activity of rat liver at neutral and acid pHT W Stephens, G J Schroepfer
The Biochemical Journal|April 1, 1984
Altered sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA in ketotic diabetic ratsG A Cook, T W Stephens, R A Harris
Diabetes|March 1, 1991
Presence of liver CGRP/amylin receptors in only nonparenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP/amylinT W Stephens, W F Heath, R N Hermeling
The Biochemical Journal|May 15, 1983
Effect of pH on malonyl-CoA inhibition of carnitine palmitoyltransferase IT W Stephens, G A Cook, R A Harris
Diabetes, Obesity & Metabolism|February 28, 2001
Lipid lowering explains the insulin sensitivity enhancing effects of a thiazolidinedione, 5-(4-(2-(2-phenyl-4-oxazolyl)ethoxy)benzyl)-2,4 thiazolidinedioneF E Yakubu-Madus, T W Stephens, W T Johnson
The Biochemical Journal|April 15, 1985
Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicineT W Stephens, A J Higgins, G A Cook, et al.
Pageof 3